Memantine Hydrochloride

CHEMBL1699 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
215.8 g/mol
LogP
Phase
4

A hydrochloride salt form of memantine, an NMDA antagonist used to treat moderate-to-severe Alzheimer's disease symptoms by regulating glutamate signaling in the brain.

Peso molecular

215,7600 g/mol

TPSA

26,00 Ų

Áreas terapéuticas

Mecanismo de acción

Non-competitive NMDA receptor antagonist.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Non-competitive NMDA receptor antagonist.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl

InChI

InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H

Molecular Formula

C12H22ClN

HBD / HBA

2 / 1

Enlaces Rotables

0

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A hydrochloride salt form of memantine, an NMDA antagonist used to treat moderate-to-severe Alzheimer's disease symptoms by regulating glutamate signaling in the brain.

Non-competitive NMDA receptor antagonist.

Yes, Memantine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1699. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 181458. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.